Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely atropine sulfate 600 microgram/1 each conventional release oral tablet (clinical drug) |
Is a |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
sulfate d'atropine 400 microgrammes/1 mL, pour injection |
Is a |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
sulfate d'atropine 600 microgrammes/1 mL, pour injection |
Is a |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
sulfate d'atropine 800 microgrammes/1 mL, pour injection |
Is a |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
sulfate d'atropine 1 mg/1 mL, pour injection |
Is a |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
sulfate d'atropine 1,25 mg/1 mL, pour injection |
Is a |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
sulfate d'atropine 3 mg/10 mL, seringue préremplie |
Is a |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
sulfate d'atropine 3 mg/30 mL, seringue préremplie |
Is a |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate 3mg/10mL injection (substance) |
Is a |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
sulfate d'atropine 1 mg/5 mL, seringue préremplie |
Is a |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate 10 mg/mL eye drops |
Is a |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate 10 mg/g eye ointment |
Is a |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate 1% single-use eye drops |
Is a |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate 0.031% eye drops (substance) |
Is a |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate 0.062% eye drops (substance) |
Is a |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate 0.1% eye drops |
Is a |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely atropine sulfate 1.25 milligram/1 milliliter conventional release eye drops (clinical drug) |
Is a |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate 0.25% eye drops (substance) |
Is a |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate 5 mg/mL eye drops |
Is a |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate 1% preservative-free eye drops (substance) |
Is a |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate 20 mg/mL eye drops |
Is a |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate 500micrograms/1mL injection (substance) |
Is a |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate 2mg/1mL injection (substance) |
Is a |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate 500micrograms/5mL s/f solution |
Is a |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate 500micrograms/5mL prefilled syringe |
Is a |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate 1mg/10mL prefilled syringe (substance) |
Is a |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate 5 mg/g eye ointment |
Is a |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate 600micrograms/1mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate [antispasmodic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely atropine sulfate 600 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate [antiarrhythmic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
sulfate d'atropine 400 microgrammes/1 mL, pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
sulfate d'atropine 600 microgrammes/1 mL, pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
sulfate d'atropine 800 microgrammes/1 mL, pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
sulfate d'atropine 1 mg/1 mL, pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
sulfate d'atropine 1,25 mg/1 mL, pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
sulfate d'atropine 3 mg/10 mL, seringue préremplie |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
sulfate d'atropine 3 mg/30 mL, seringue préremplie |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate 3mg/10mL injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
sulfate d'atropine 1 mg/5 mL, seringue préremplie |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate 10 mg/g eye ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate 1% single-use eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate [premedication] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate 0.031% eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate 0.062% eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate 0.1% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely atropine sulfate 1.25 milligram/1 milliliter conventional release eye drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate 0.25% eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate 5 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate 1% preservative-free eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate 20 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate 500micrograms/1mL injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate 2mg/1mL injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate 500micrograms/5mL s/f solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate 500micrograms/5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate 1mg/10mL prefilled syringe (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate 5 mg/g eye ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate 1% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate 0.4mg tablet (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-phenotrope 2.5mg/25micrograms tablet (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-phenotrope |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate + diphenoxylate hydrochloride 0.025mg/2.5mg liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate 140mcg/edrophonium chloride 10mg injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-phenotrope |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulphate+edrophonium chloride (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing atropine sulfate and hyoscyamine sulfate and scopolamine hydrobromide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate 10 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely atropine 25 microgram and difenoxin hydrochloride 1 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Morphine sulfate+atropine sulfate 10mg/600micrograms/1mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate monohydrate |
Is a |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely atropine sulfate 600 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely atropine sulfate 600 microgram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Atropine sulfate 0.4mg tablet (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Atropine sulfate 0.4mg tablet (product) |
Has basis of strength substance (attribute) |
True |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Atropine sulfate monohydrate |
Is modification of (attribute) |
True |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atropine sulfate 500micrograms/5mL conventional release oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely atropine sulfate 600 microgram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 mg oral tablet |
Has precise active ingredient |
True |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Atropine sulfate 0.4mg tablet (product) |
Has precise active ingredient |
True |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely atropine sulfate 1.25 milligram/1 milliliter conventional release eye drops (clinical drug) |
Has basis of strength substance (attribute) |
True |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely atropine sulfate 1.25 milligram/1 milliliter conventional release eye drops (clinical drug) |
Has precise active ingredient |
True |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Atropine sulfate 5 mg/mL eye drops |
Has basis of strength substance (attribute) |
True |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Atropine sulfate 5 mg/mL eye drops |
Has precise active ingredient |
True |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Atropine sulfate 20 mg/mL eye drops |
Has basis of strength substance (attribute) |
True |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Atropine sulfate 20 mg/mL eye drops |
Has precise active ingredient |
True |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Atropine sulfate 10 mg/mL eye drops |
Has precise active ingredient |
True |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Atropine sulfate 10 mg/mL eye drops |
Has basis of strength substance (attribute) |
True |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Atropine sulfate 10 mg/g eye ointment |
Has precise active ingredient |
True |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Atropine sulfate 10 mg/g eye ointment |
Has basis of strength substance (attribute) |
True |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely atropine sulfate 1 milligram/10 milliliter conventional release solution for injection syringe |
Has basis of strength substance (attribute) |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely atropine sulfate 1 milligram/10 milliliter conventional release solution for injection syringe |
Has precise active ingredient |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely atropine sulfate 1.25 milligram/1 milliliter conventional release solution for injection ampule |
Has precise active ingredient |
False |
Atropine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |